tirzepatide · Eli Lilly
Mounjaro tracker
Mounjaro is a once-weekly tirzepatide injection. It acts on both the GLP-1 and GIP receptors and is usually started at a low dose that your prescriber steps up over several months. That makes a clear record of every shot, dose change and side effect especially useful.
What to track on Mounjaro
- The day and time of each weekly shot
- Your current dose and the date each dose change started
- Which injection site you used (abdomen, thigh or upper arm)
- Side effects such as nausea, constipation or fatigue, and how strong they felt
- Appetite and food noise across the week
- Weight as a trend rather than a daily number
Common side effects to log
Commonly reported side effects in the prescribing information include nausea, diarrhoea, reduced appetite, vomiting, constipation, indigestion and abdominal pain. They are often more noticeable after a dose increase.
Your patient information leaflet has the full list. Contact your prescriber or pharmacist if a side effect worries you.
How Levli helps on Mounjaro
Levli keeps your once-weekly injection schedule, dose history, injection sites, symptoms and weight trend together, so you can see how they relate over time. Estimated medication levels are shown as illustrative curves, not clinical measurements, and you can export a PDF history to bring to appointments.
Understand your GLP-1 journey
Levli brings your doses, symptoms and progress together in one private, calm place.
Start trackingRelated
Levli is not a medical service and this page is general information, not medical advice. Always consult your healthcare provider about your medication, dose or health. Medication level estimates in Levli are illustrative only.